| Item 5.07 |
Submission of Matters to a Vote of Security Holders. |
On July 22, 2026, Taylor Morrison Home Corporation, a Delaware corporation (“TMHC”), held a special meeting of stockholders (the “TMHC Special Meeting”) at which holders of TMHC’s common stock, par value $0.00001 per share (“TMHC Common Stock”), voted on the proposals identified in the definitive proxy statement filed with the Securities and Exchange Commission on June 23, 2026 relating to the transactions contemplated by the Agreement and Plan of Merger, dated as of May 31, 2026 (as amended or modified from time to time, the “Merger Agreement”), by and among TMHC, Berkshire Hathaway Inc., a Delaware corporation (“Parent”), and WXYZ Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent (“Merger Sub”). Of the 91,999,956 shares of TMHC Common Stock issued and outstanding and entitled to vote at the close of business on June 22, 2026, the record date for the TMHC Special Meeting, 78,171,662 shares were present in person or represented by proxy at the TMHC Special Meeting, which constituted a quorum. The voting results were as follows:
1. The proposal to adopt the Merger Agreement (the “Merger Proposal”), pursuant to which, subject to the terms and conditions set forth therein, Merger Sub will be merged with and into TMHC, the separate corporate existence of Merger Sub will cease, and TMHC will survive the merger as a wholly owned subsidiary of Parent (the “Merger”):
|
|
|
|
|
| Votes For |
|
Votes Against |
|
Abstentions |
| 75,830,360 |
|
2,333,091 |
|
8,211 |
2. The proposal to approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to the named executive officers of TMHC in connection with the consummation of the Merger:
|
|
|
|
|
| Votes For |
|
Votes Against |
|
Abstentions |
| 70,009,828 |
|
8,095,053 |
|
66,781 |
3. In connection with the TMHC Special Meeting, the board of directors of TMHC also solicited proxies with respect to the proposal to adjourn the TMHC Special Meeting from time to time, as determined in accordance with the Merger Agreement by the board of directors of TMHC, including for the purpose of soliciting additional votes for the approval of the Merger Proposal if there were insufficient votes at the time of the TMHC Special Meeting to approve the Merger Proposal (the “Adjournment Proposal”). The Adjournment Proposal was not submitted to TMHC stockholders for approval at the TMHC Special Meeting because a quorum of stockholders entitled to vote at the TMHC Special Meeting was present or represented by proxy and the TMHC stockholders approved the Merger Proposal.
Forward-Looking Statements
This Form 8-K contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. Forward-looking statements include, but are not limited to, statements concerning the Company’s expectations, plans, intentions, strategies or prospects with respect to the proposed Merger. These statements are often identified by the use of words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “hope,” “hopeful,” “likely,” “optimistic,” “possible,” “potential,” “preliminary,” “project,” “should,” “will,” “would” or the negative or plural of these words or similar expressions or variations. Forward-looking statements are made based upon management’s current expectations and beliefs and are not guarantees of future performance. Such forward-looking statements are subject to a number of risks, uncertainties, assumptions and other factors that could cause actual results and the timing of certain events to differ materially from future results expressed or implied by the forward-looking statements. These factors include, among others: (i) the ability of the parties to complete the proposed transaction on the anticipated terms and timing, or at all, (ii) the satisfaction or waiver of other conditions to the completion of the proposed transaction, including obtaining required shareholder and regulatory approvals; (iii) the risk that the Company’s stock price may fluctuate during the pendency of the proposed transaction and may decline if the proposed transaction is not completed; (iv) potential litigation relating to the proposed transaction that could be instituted against the Company or its directors or officers, including the delay, expense or other effects of any outcomes related thereto; (v) the risk that disruptions from the proposed transaction will harm the Company’s business, including current plans and operations, including during the pendency of the proposed transaction; (vi) the ability of the Company to retain, motivate, and hire key personnel; (vii) the diversion of management’s time and attention from ordinary course business operations to completion of the proposed transaction and integration matters; (viii) potential adverse reactions or changes to business relationships resulting from the announcement, pendency or completion of the proposed transaction; (ix) legislative, regulatory and economic